Results 31 to 40 of about 8,495 (166)

Abdominal Compartment Syndrome Secondary to Chronic Constipation

open access: yesCase Reports in Pediatrics, 2011
Abdominal compartment syndrome (ACS) is defined as an elevated intraabdominal pressure with evidence of organ dysfunction. The majority of published reports of ACS are in neonates with abdominal wall defects and in adults following trauma or burns, but ...
Helene Flageole   +3 more
doaj   +1 more source

A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336

open access: yesFrontiers in Pharmacology, 2018
Background: Preclinical and clinical data suggest that a compound which binds potently to and inhibits the dopamine transporter, but with a slower onset and offset rate than cocaine and with less abuse potential and psychomotor stimulant activity, could ...
F. Ivy Carroll   +4 more
doaj   +1 more source

The effect of elastic abdominal binder use on respiratory function on persons with high spinal cord injury at orthostatic position [PDF]

open access: yes, 2015
Introduction : Spinal cord injury causes respiratory muscles paralysis, especially in high thoracic paraplegia and tetraplegia with injury above or right on the sixth thoracic segment, and also biomechanics, volumes, capacities and respiratory pressures ...
Cardoso, Jefferson R.   +4 more
core   +1 more source

Randomised clinical trial: Polyethylene glycol 3350 with sports drink vs. polyethylene glycol with electrolyte solution as purgatives for colonoscopy--the incidence of hyponatraemia. [PDF]

open access: yes, 2014
BACKGROUND: Polyethylene glycol 3350 plus sports drink (PEG-SD) is a hypo-osmotic purgative commonly used for colonoscopy, though little safety data are available. AIM: To evaluate the effect of PEG-SD on serum sodium (Na) and other electrolytes compared
Aronchick   +18 more
core   +2 more sources

Fall Risk Assessment Experience

open access: yesMedEdPORTAL, 2010
Falls are common in older adults and result in significant morbidity, including injury, pain, disability, and even death. Risk factors for falling have been identified, and interventions to improve these risk factors have been found to reduce fall rates ...
Sara Bradley, Reena Karani
doaj   +1 more source

A Young Female Who Develops Tachycardia and Orthostatic Intolerance Following a Recent Infection [PDF]

open access: yes, 2013
Case Presentation The patient is a 20-year-old female with a history of asthma and anxiety with panic attacks who presented with palpitations and lightheadedness/pre-syncope. The morning of admission, she was attending a seminar and experienced an acute
Valentino, MD, PhD, Michael A.
core   +2 more sources

The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management [PDF]

open access: yes, 2006
Postural tachycardia syndrome (POTS), characterized by orthostatic tachycardia in the absence of orthostatic hypotension, has been the focus of increasing clinical interest over the last 15 years 1. Patients with POTS complain of symptoms of tachycardia,
Raj, Satish R
core   +1 more source

Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT‐1186‐A02)

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is approved in the US for the treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed IV edaravone slows the rate of physical functional decline.
Jeffrey Rothstein   +17 more
wiley   +1 more source

Hypovolaemic shock: assessment, pathophysiology and nursing care [PDF]

open access: yes, 2017
Hypovolaemia leads to a number of key physiological responses which require systematic assessment and interpretation. This article focuses on a case study involving a patient with Parkinson’s disease who became hypovolaemic following a fall at home, to ...
McLeod, A., Moruzzi, M.
core   +1 more source

Disease modifying therapy for multiple system atrophy – Parkinsonian Type [PDF]

open access: yes, 2017
BACKGROUND: Multiple System Atrophy –Parkinsonian Type (MSA-P) is a rare, rapidly progressive neurodegenerative disease without any current treatment.
Dwyer, Sean Sullivan
core  

Home - About - Disclaimer - Privacy